BECCIOLINI, ANDREA

BECCIOLINI, ANDREA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 19 di 19 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: Focus on interchangeability 28-giu-2017 Becciolini A.Raimondo M. G.Crotti C.Agape E.Biggioggero M.Favalli E. G. Article (author) -
Change over time in the pattern of clinical response to first-line biologic drugs in patients with rheumatoid arthritis: Observational data in a real-life setting 1-feb-2017 Favalli E. G.Becciolini A.Meroni P. L. Article (author) -
Eight-year retention rate of first-line tumor necrosis factor inhibitors in spondyloarthritis : A multi-center retrospective analysis 1-ott-2016 E. G. FavalliC. SelmiA. BeccioliniM. Biggioggero + Article (author) -
Is there a need for new thresholds to define remission and low disease activity by disease activity score 28 calculated with C reactive protein? real life data from a local registry 1-gen-2015 Favalli E. G.Becciolini A.Biggioggero M.Meroni P. L. + Article (author) -
Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations : similarities and differences 1-ago-2017 Favalli E. G.Becciolini A.Biggioggero M.Ughi N.Romano M.Crotti C.Meroni P. L. + Article (author) -
Reliability and validity of the Italian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in patients with systemic sclerosis 1-gen-2015 R. GualtierottiF. IngegnoliP.L. MeroniADORNI, GIUDITTAA. BeccioliniG. MarfiaL. ScaloneN. Ughi + Article (author) -
Sarilumab : patient-reported outcomes in rheumatoid arthritis 1-ago-2018 Chiara CrottiMartina BiggioggeroAndrea BeccioliniEnnio Giulio Favalli Article (author) -
Sex and Management of Rheumatoid Arthritis 1-giu-2019 Favalli E. G.Biggioggero M.Crotti C.Becciolini A.Raimondo M. G.Meroni P. L. Article (author) -
Spotlight on mavrilimumab for the treatment of rheumatoid arthritis : Evidence to date 1-gen-2017 Crotti C.Raimondo M. G.Becciolini A.Biggioggero M.Favalli E. G. Article (author) -
Structural integrity versus radiographic progression in rheumatoid arthritis 1-ago-2015 Favalli E. G.Becciolini A.Biggioggero M. Article (author) -
Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis 1-gen-2016 Cantini F.Nannini C.Favalli E. G.Becciolini A.Biggioggero M.Infantino M. + Article (author) -
Targeting Granulocyte-Monocyte Colony-Stimulating Factor Signaling in Rheumatoid Arthritis: Future Prospects 1-nov-2019 Crotti C.Agape E.Becciolini A.Biggioggero M.Favalli E. G. Article (author) -
The 12-item psoriatic arthritis impact of disease questionnaire : Construct validity, reliability, and interpretability in a clinical setting 1-mar-2017 Becciolini A.Crotti C.Favalli E. G. + Article (author) -
The management of first-line biologic therapy failures in rheumatoid arthritis : current practice and future perspectives 1-gen-2017 Favalli E. G.Raimondo M. G.Becciolini A.Biggioggero M.Caporali R. + Article (author) -
The profiling of axial spondyloarthritis patient candidate to a biologic therapy : consensus from a Delphi-panel of Italian experts 1-gen-2018 Favalli E. G.Becciolini A.Caporali R. + Article (author) -
The role of concomitant methotrexate dosage and maintenance over time in the therapy of rheumatoid arthritis patients treated with adalimumab or etanercept : Retrospective analysis of a local registry 1-mag-2018 Favalli E. G.Becciolini A.Biggioggero M.Crotti C.Raimondo M. G. + Article (author) -
The role of methotrexate as combination therapy with etanercept in rheumatoid arthritis: Retrospective analysis of a local registry 1-gen-2016 Becciolini A.Biggioggero M.Favalli E. G. Article (author) -
Tocilizumab in the treatment of rheumatoid arthritis : An evidence-based review and patient selection 1-gen-2019 Biggioggero M.Crotti C.Becciolini A.Favalli E. G. Article (author) -
Two-year persistence of golimumab as second-line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors : real-life data from the LORHEN registry 1-feb-2018 Favalli, Ennio G.Becciolini, AndreaSarzi-Puttini, P.Caporali, Roberto + Article (author) -